Turn Therapeutics (TTRX) Cash from Operations (2024 - 2026)
Turn Therapeutics (TTRX) recorded quarterly Cash from Operations of 1600000.0 in Q1 2026, down 36.41% quarter-over-quarter from 1172901.0 in Q4 2025, and down 436.81% on a YoY basis from 475047.71 in Q1 2025.
Turn Therapeutics (TTRX) Cash from Operations (2024 - 2026) Analysis & Trends
Turn Therapeutics' Cash from Operations history runs 3 years deep, the most recent figure standing at 1600000.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 436.81% year-over-year to 1600000.0; the TTM figure through Mar 2026 stood at 3501504.0 (changed N/A YoY), while the FY2025 annual figure was 2562901.0, down 88.27% from the prior year.
- Cash from Operations was 1600000.0 for Q1 2026 at Turn Therapeutics, down from 1172901.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 298058.0 in Q1 2025 to a low of 1600000.0 in Q1 2026.
- Historically, Cash from Operations has averaged 875376.0 across 3 years, with a median of 801723.0 in 2024.
- The sharpest annual moves came in 2025 and 2026: Cash from Operations sank 172.42% in 2025, then tumbled 436.81% in 2026.
- A 3-year view of Cash from Operations shows it stood at 430545.0 in 2024, then sank by 172.42% to 1172901.0 in 2025, then sank by 36.41% to 1600000.0 in 2026.
- The last three Cash from Operations figures came in at 1600000.0 (Q1 2026), 1172901.0 (Q4 2025), and 298058.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Turn Therapeutics | 178.62 Mn | 178.62 Mn | - | -1.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.60 Mn |
| Mar 31, 2026 | -1.60 Mn |
| Dec 31, 2025 | -1.17 Mn |
| Dec 31, 2025 | -1.17 Mn |
| Mar 31, 2025 | -298,058.00 |
| Mar 31, 2025 | -298,058.00 |
| Dec 31, 2024 | -430,545.00 |
| Dec 31, 2024 | -430,545.00 |